About Homeobox even-skipped homolog protein 2
Homeobox even-skipped homolog protein 2 (EVX2) is a protein
from Homo sapiens identified by UniProt accession
Q03828, 476 residues long.
MolForge cross-references it against 0 known binders and
330 disease associations.
Target properties
| Protein name | Homeobox even-skipped homolog protein 2 |
| UniProt accession | Q03828 |
| Gene | EVX2 |
| Organism | Homo sapiens |
| Length | 476 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (330)
Diseases linked to this target (Open Targets).
- neurodegenerative disease · score 0.34
- Alzheimer disease · score 0.34
- multiple sclerosis · score 0.34
- Parkinson disease · score 0.34
- lysosomal storage disease · score 0.34
- synpolydactyly type 1 · score 0.28
- urate measurement · score 0.26
- glomerular filtration rate · score 0.11
- brachydactyly type A2 · score 0.09
- familial digital arthropathy-brachydactyly · score 0.09
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q03828-F1 | alphafold | PREDICTED | 54.10 | — |
Amino-acid sequence (476 residues)
MMERIRKEMI LMERGLHSPT AGKRFSNLSN SAGNAVLEAL ENSQHPARLS PRLPSAPLHS ALGELPAKGK FEIDTLFNLQ HTGSESTVSS EISSAAESRK KPGHYSEAAA EADMSSDVEV GCSALRSPGG LGAAQLKENN GKGYAESGSA AGTTTSASGS GLGSLHGGSG GSGGSAALGG SGSGADQVRR YRTAFTREQI ARLEKEFYRE NYVSRPRRCE LAAALNLPET TIKVWFQNRR MKDKRQRLAM SWPHPADPSF YTYMMTHAAA TGSLPYPFHS HVPLHYYPHV GVTAAAAAAA ASGAAAAASS PFATSIRPLD TFRALSHPYS RPELLCSFRH PGLYQAPAAA AGLNSAASAA AAAAAAAAAA SSAAAAGAPP SGGSAPCSCL SCHSSQSAAA AAAAAAAALG SRGGGGGGGG GGGGGGGGAG AGGGSDFGCS AAAPRSESGF LPYSAAVLSK TAVSPPDQRD EAPLTR
Explore Homeobox even-skipped homolog protein 2 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets